AUTHOR OF THIS BLOG

DR ANTHONY MELVIN CRASTO, WORLDDRUGTRACKER

DR ANTHONY MELVIN CRASTO Ph.D

DR ANTHONY MELVIN CRASTO, Worlddrugtracker, Born in Mumbai in 1964 and graduated from Mumbai University, Completed his PhD from ICT ,1991, Mumbai, India, in Organic chemistry, The thesis topic was Synthesis of Novel Pyrethroid Analogues, Currently he is working with AFRICURE PHARMA as ADVISOR earlier GLENMARK LS Research centre as consultant,Principal Scientist, Process Research (bulk actives) at Mahape, Navi Mumbai, India. Prior to joining Glenmark, he worked with major multinationals like Hoechst Marion Roussel, now sSanofi, Searle India ltd, now Rpg lifesciences, etc. he is now helping millions, has million hits on google on all organic chemistry websites. His New Drug Approvals, Green Chemistry International, Eurekamoments in organic chemistry are some most read blogs He has hands on experience in initiation and developing novel routes for drug molecules and implementation them on commercial scale over a 32 year tenure, good knowledge of IPM, GMP, Regulatory aspects, he has several international drug patents published worldwide . He gas good proficiency in Technology transfer, Spectroscopy, Stereochemistry, Synthesis, polymorphism etc He suffered a paralytic stroke in dec 2007 and is bound to a wheelchair, this seems to have injected feul in him to help chemists around the world, he is more active than before and is pushing boundaries, he has one lakh connections on all networking sites, He makes himself available to all, contact him on +91 9323115463, [email protected]

CFDA Approves Clinical Trials for Novel China AIDS Treatment, Azi Fu (Azvudine)

 AIDS, Uncategorized  Comments Off on CFDA Approves Clinical Trials for Novel China AIDS Treatment, Azi Fu (Azvudine)
May 282013
 

Links

http://newdrugapprovals.wordpress.com/2013/05/28/cfda-approves-clinical-trials-for-novel-china-aids-treatment-azi-fu-azvudine/

Share

Swedish pharmaceutical company Moberg Pharma has completed enrolling patients in the ongoing Phase II trial of MOB-015 for the treatment of nail fungus (onychomycosis).

 phase 2  Comments Off on Swedish pharmaceutical company Moberg Pharma has completed enrolling patients in the ongoing Phase II trial of MOB-015 for the treatment of nail fungus (onychomycosis).
May 282013
 

Links

http://newdrugapprovals.wordpress.com/2013/05/28/swedish-pharmaceutical-company-moberg-pharma-has-completed-enrolling-patients-in-the-ongoing-phase-ii-trial-of-mob-015-for-the-treatment-of-nail-fungus-onychomycosis/

Share

Sonepcizumab/LT1009-US-based Lpath has begun patient dosing in Phase 2a single-arm trial of anti-cancer drug, Asonep.

 phase 2  Comments Off on Sonepcizumab/LT1009-US-based Lpath has begun patient dosing in Phase 2a single-arm trial of anti-cancer drug, Asonep.
May 282013
 

Links

http://newdrugapprovals.wordpress.com/2013/05/28/sonepcizumablt1009-us-based-lpath-has-begun-patient-dosing-in-phase-2a-single-arm-trial-of-anti-cancer-drug-asonep/

Share

Xarelto approved for Secondary prevention in Acute Coronary Syndrome patients in Europe

 china  Comments Off on Xarelto approved for Secondary prevention in Acute Coronary Syndrome patients in Europe
May 272013
 

 

 

shark

read all

Links

http://newdrugapprovals.wordpress.com/2013/05/27/xarelto-approved-for-secondary-prevention-in-acute-coronary-syndrome-patients-in-europe/

Share

China’s Curative Medical to Seek CFDA Approval for ALung’s Respiratory Device

 china, Uncategorized  Comments Off on China’s Curative Medical to Seek CFDA Approval for ALung’s Respiratory Device
May 272013
 

 

Links

read all at

http://newdrugapprovals.wordpress.com/2013/05/27/chinas-curative-medical-to-seek-cfda-approval-for-alungs-respiratory-device/

Share

AbbVie and Eisai Announce HUMIRA® Pre-filled Syringe Has Received Approval for the Treatment of Intestinal Behçet’s Disease in Japan

 Uncategorized  Comments Off on AbbVie and Eisai Announce HUMIRA® Pre-filled Syringe Has Received Approval for the Treatment of Intestinal Behçet’s Disease in Japan
May 272013
 

Links

 

read all at

http://newdrugapprovals.wordpress.com/2013/05/27/abbvie-and-eisai-announce-humira-pre-filled-syringe-has-received-approval-for-the-treatment-of-intestinal-behcets-disease-in-japan/

Share
Follow

Get every new post on this blog delivered to your Inbox.

Join other followers: